Artificial intelligence could be used to predict who is at risk of developing type 2 diabetes--information that could be used to improve the lives of millions of Canadians. Researchers at the University of Toronto used a machine learning model to analyze health data, collected between 2006 to 2016, of 2.1 million people living in Ontario. They found that they were able to use the model to accurately predict the number of people who would develop type 2 diabetes within a five-year time period. The machine learning model was also able to analyze different factors that would influence whether people were high or low risk to develop the disease. The results of the study were recently published in the journal JAMA Network Open.

Artificial intelligence could be used to predict who is at risk of developing type 2 diabetes – information that could be used to improve the lives of millions of Canadians. Researchers at the University of Toronto used a machine learning model to analyze health data, collected between 2006 to 2016, of 2.1 million people living in Ontario. They found that they were able to use the model to accurately predict the number of people who would develop type 2 diabetes within a five-year time period. The machine learning model was also able to analyze different factors that would influence whether people were high or low risk to develop the disease. The results of the study were recently published in the journal JAMA Network Open.

Our daily interactions with technology create vast amounts of data and analytics giving rise to what has been dubbed the "artificial intelligence revolution." Now, a new research centre at the University of Toronto's Temerty Faculty of Medicine aims to harness the incredible promise of AI in the realms of medicine and health care. The Temerty Centre for Artificial Intelligence Research and Education in Medicine (T-CAIREM) launched this week at U of T, solidifying Toronto's place at the nexus of AI, data science and the health sciences. "Toronto is uniquely positioned to lead globally in artificial intelligence in healthcare," says Professor Muhammad Mamdani, who was recently appointed the inaugural director of T-CAIREM for a five-year term. "Our expertise in medicine and allied health sciences, computer science, statistics, mathematics and engineering is among the best in the world."